Kindly find the attached compliance certificate under Regulation 74 (5) of SEBI (Depository and Participant) Regulation, 2018 for the quarter ended 31st March, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dipna Pharmachem Limited has submitted a quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2025. The certificate was issued by Bigshare Services Private Limited, the company's Registrar and Share Transfer Agent (RTA), and confirms that all securities received from depository participants for dematerialization were accepted or rejected by the depositories. It further confirms that physical share certificates received for conversion into demat form were properly mutilated and cancelled, and the depositories' names were recorded as the registered owners in the company's register of members within the mandated 15-day period. The filing was signed by Managing Director Keyur Shah on 7th April, 2025 and is purely procedural in nature.
This is a routine regulatory compliance filing with no material impact on the company's financials, operations, or shareholders. It simply demonstrates that the company's share transfer process is functioning in line with SEBI requirements.